GSK plc
GSK plc (NYSE: GSK) is trading at $46.54, about ₹4,509 at today's USD/INR rate, as of 8 Oct 2026, 4:00 PM ET, down 1.02% today. Indian residents can buy GSK from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$45.83
Today's high
$46.69
52 week low
$42.85
52 week high
$61.70
GSK opened at $46.40, closed previously at $47.02, and has traded between $42.85 and $61.70 over the past 52 weeks.
About
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.
Key statistics
Avg. volume
3.83M
Market cap
$93.24B
P/E Ratio
14.46
Price-to-sales ratio
2.09
Enterprise value
£88.02B
Free cash flow yield
7.90%
Debt-to-equity ratio
1.03
Return on equity
34.96%
ROIC
16.61%
Beta
0.29
Dividend yield
3.92%
Last dividend
$1.82
Financial overview
Revenue
£32.67B
Earnings per share
£2.82
Free cash flow
£5.82B
Net profit margin
14.52%
Gross margin
73.29%
EBITDA
£10.40B
Revenue growth
4.11%
Similar securities
This is not an investment recommendation
How to buy GSK from India
Indian residents can buy GSK shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in GSK from India
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for GSK and place an order
Find GSK by name or by its ticker, GSK, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. GSK trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your GSK position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Trading and taxes when buying GSK from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. GSK’s current yield is 3.92%.Dividend tax explained
FAQs
Can Indian residents buy GSK stock?
Yes. GSK (GSK) has been listed on the New York Stock Exchange since 1980, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one GSK share cost in rupees?
One GSK share is $46.54 — about ₹4,509 at a USD/INR rate of 96.88 on 8 Oct 2026. Both the GSK price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying GSK from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of GSK?
Yes. One GSK share is $46.54, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in GSK.
How are gains on GSK shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the GSK price. Paasa issues a capital-gains statement for your return.
Does GSK pay a dividend, and how is it taxed in India?
Yes. GSK pays a dividend and the current yield is 3.92%; the last declared dividend was $1.82 per share, about ₹176.05. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade GSK from India?
The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is GSK a United States company, and does that change how it is taxed?
GSK trades on the New York Stock Exchange in US dollars, but the company is domiciled in United Kingdom. GSK trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare GSK shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your GSK holding, its cost and its closing value.
How do I sell GSK and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.